Advertisement

Expression of Complete Antibodies in Transgenic Plants

  • Doreen M. FlossEmail author
  • Udo Conrad
Protocol
Part of the Springer Protocols Handbooks book series (SPH)

Plants are attractive vehicles for the expression of recombinant proteins as they are inexpensive and versatile systems, amenable to rapid and economic scale-up. Furthermore, transgenic plants can be established in resource-poor areas, where the demand for pharmaceutical proteins is greatest, but where the financial resources to pay for them are the most limited. Since the first report of a recombinant antibody expressed in transgenic plants, various antibody derivatives have been produced in different crop species. Human monoclonal antibodies, which posses a neutralizing capacity against HIV-1 have been successfully expressed in transgenic plants. The production of a full-length anti-HIV-1 antibody in tobacco seeds will be described in the following chapter. It starts with the construction of the binary vectors for Agrobacterium-mediated leaf disk transformation of tobacco and closes with the selection of progeny plants containing the transgenes for both immunoglobulin chain genes, and accumulating the assembled antibody. Protocols for the characterization of transgenic plants, multiplex PCR, Western blot analysis and ELISA techniques, are presented and explained.

Keywords

Human Immunodeficiency Virus Transgenic Plant Tobacco Plant Leaf Disk Seed Extract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Altpeter F, Baisakh N, Beachy R, Bock R, Capell T, Christou P, Daniell H, Datta K, Datta S, Dix PJ, Fauquet C, Huang N, Kohli A, Mooibroek H, Nicholson L, Nguyen TT, Nugent G, Raemakers K, Romano A, Somers DA, Stoger E, Taylor N, Visser R (2005) Particle bombardment and the genetic enhancement of crops: myths and realities. Mol Breeding 15:305–327CrossRefGoogle Scholar
  2. Armbruster C, Stiegler GM, Vcelar BA, Jager W, Michael NL, Vetter N, Katinger H (2002) A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1. AIDS 16:227–233PubMedCrossRefGoogle Scholar
  3. Armbruster C, Stiegler GM, Vcelar BA, Jager W, Koller U, Jilch R, Ammann CG, Pruenster M, Stoiber H, Katinger H (2004) Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12. J Antimicrob Chemother 54:915–920PubMedCrossRefGoogle Scholar
  4. Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu WD, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Lu YC, Wright JE, Chou TC, Ruprecht RM (2000) Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 6:200–206PubMedCrossRefGoogle Scholar
  5. Barton KA, Binns AN, Matzke AJM, Chilton MD (1983) Regeneration of intact tobacco plants containing full length copies of genetically engineered T-DNA, and transmission of T-DNA to R1 progeny. Cell 32:1033–1043PubMedCrossRefGoogle Scholar
  6. Baumlein H, Wobus U, Pustell J, Kafatos FC (1986) The legumin gene family - structure of a B type gene of Vicia faba and a possible legumin gene specific regulatory element. Nucleic Acids Res 14:2707–2720PubMedCrossRefGoogle Scholar
  7. Baumlein H, Boerjan W, Nagy I, Bassuner R, Van Montagu M, Inze D, Wobus U (1991) A novel seed protein gene from Vicia faba is developmentally regulated in transgenic tobacco and Arabidopsis plants. Mol Gen Genet 225:459–467Google Scholar
  8. Bevan M (1984) Binary Agrobacterium vectors for plant transformation. Nucleic Acids Res 12:8711–8721PubMedCrossRefGoogle Scholar
  9. Boehm R (2007) Bioproduction of therapeutic proteins in the 21st century and the role of plants and plant cells as production platforms. In: Lal S (ed) Biology of emerging viruses: Sars, Avian and Human Influenza, Metapneumovirus, Nipah, West Nile, and Ross River Virus. Blackwell Publishing, Uxford, pp 121–134Google Scholar
  10. Casadevall A, Dadachova E, Pirofski L (2004) Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2:695–703PubMedCrossRefGoogle Scholar
  11. Conrad U, Fiedler U, Artsaenko O, Phillips J (1997) Single-chain antibodies expressed in plants. In: Cunninham C, Porter S (eds) Methods in Biotechnology – Recombinant proteins from plants: Production and isolation of clinically useful compounds. Humana Press, Totowa, pp 103–127Google Scholar
  12. Deblaere R, Bytebier B, Degreve H, Deboeck F, Schell J, Van Montagu M, Leemans J (1985) Efficient octopine Ti plasmid-derived vectors for Agrobacterium-mediated gene transfer to plants. Nucleic Acids Res 13:4777–4788PubMedCrossRefGoogle Scholar
  13. During K, Hippe S, Kreuzaler F, Schell J (1990) Synthesis and self-assembly of a functional monoclonal antibody in transgenic Nicotiana tabacum. Plant Mol Biol 15:281–293PubMedCrossRefGoogle Scholar
  14. Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC (2008) HIV vaccine research: the way forward. Science 321:530–532PubMedCrossRefGoogle Scholar
  15. Fiedler U, Conrad U (1995) High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds. Biotechnology 13:1090–1093PubMedCrossRefGoogle Scholar
  16. Floss DM, Sack M, Stadlmann J, Rademacher T, Scheller J, Stoger E, Fischer R, Conrad U (2008) Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. Plant Biotechnol J 6:379–391PubMedCrossRefGoogle Scholar
  17. Floss DM, Sack M, Arcalis E, Stadlmann J, Quendler H, Rademacher T, Stoger E, Scheller J, Fischer R, Conrad U (2009a) Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Plant Biotechnol J 7:899–913Google Scholar
  18. Floss DM, Kumlehn J, Conrad U, Saalbach I (2009b) Haploid technology allows for the efficient and rapid generation of homozygous antibody-accumulating transgenic tobacco plants. Plant Biotechnol J 7:1–9Google Scholar
  19. Gahrtz M, Conrad U (2009) Immunomodulation of plant function by in vitro selected single-chain Fv intrabodies. In: Faye L, Gomord V (eds) Methods in Molecular Biology: Recombinant proteins from plants. Humana Press, TotowaGoogle Scholar
  20. Hiatt A, Cafferkey R, Bowdish K (1989) Production of antibodies in transgenic plants. Nature 342:76–78PubMedCrossRefGoogle Scholar
  21. Joos B, Trkola A, Kuster H, Aceto L, Fischer M, Stiegler G, Armbruster C, Vcelar B, Katinger H, Guenthard HF (2006) Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5). Antimicrob Agents Chemother 50:1773–1779PubMedCrossRefGoogle Scholar
  22. Ma JKC, Lehner T, Stabila P, Fux CI, Hiatt A (1994) Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants. Eur J Immunol 24:131–138PubMedCrossRefGoogle Scholar
  23. Ma JKC, Chikwamba R, Sparrow P, Fischer R, Mahoney R, Twyman RM (2005) Plant-derived pharmaceuticals - the road forward. Trends Plant Sci 10:580–585PubMedCrossRefGoogle Scholar
  24. Mascola JR, Lewis MG, Stiegler G, Harris D, Van Cott TC, Hayes D, Louder MK, Brown CR, Sapan CV, Frankel SS, Lu YC, Robb ML, Katinger H, Birx DL (1999) Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol 73:4009–4018PubMedGoogle Scholar
  25. Mascola JR, Stiegler G, Van Cott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG (2000) Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 6:207–210PubMedCrossRefGoogle Scholar
  26. Munro S, Pelham HR (1986) An Hsp70-like protein in the ER: Identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 46:291–300PubMedCrossRefGoogle Scholar
  27. Munro S, Pelham HR (1987) A C-terminal signal prevents secretion of luminal ER proteins. Cell 48:899–907PubMedCrossRefGoogle Scholar
  28. Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G, Ruker F, Katinger H (1993) A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67:6642–6647PubMedGoogle Scholar
  29. Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F, Tauer C, Berger R, Barrett N, Jungbauer A (1994) A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 10:1651–1658PubMedCrossRefGoogle Scholar
  30. Rademacher T, Sack M, Arcalis E, Stadlmann J, Balzer S, Altmann F, Quendler H, Stiegler G, Kunert R, Fischer R, Stoger E (2008) Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans. Plant Biotechnol J 6:189–201PubMedCrossRefGoogle Scholar
  31. Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G, Labrou N, Altmann F, Ma J, Stoger E, Capell T, Christou P (2008) Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci USA 105:3727–3732PubMedCrossRefGoogle Scholar
  32. Sambrook J, Russell DW (2001) Molecular cloning – a laboratory manual. Cold Spring Harbor Laboratory Press, New YorkGoogle Scholar
  33. Shattock RJ, Moore JP (2003) Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 1:25–34PubMedCrossRefGoogle Scholar
  34. Stoger E, Ma JKC, Fischer R, Christou P (2005a) Sowing the seeds of success: Pharmaceutical proteins from plants. Curr Opin Biotechnol 16:167–173PubMedCrossRefGoogle Scholar
  35. Stoger E, Sack M, Nicholson L, Fischer R, Christou P (2005b) Recent progress in plantibody technology. Curr Pharma Des 11:2439–2457CrossRefGoogle Scholar
  36. Teli NP, Timko MP (2004) Recent developments in the use of transgenic plants for the production of human therapeutics and biopharmaceuticals. Plant Cell Tiss Organ Cult 79:125–145CrossRefGoogle Scholar
  37. Twyman RM, Schillberg S, Fischer R (2005) Transgenic plants in the biopharmaceutical market. Expert Opin Emerg Drugs 10:185–218PubMedCrossRefGoogle Scholar
  38. Tzfira T, Citovsky V (2006) Agrobacterium-mediated genetic transformation of plants: Biology and biotechnology. Curr Opin Biotechnol 17:147–154PubMedCrossRefGoogle Scholar
  39. Van Larebeke N, Engler G, Holsters M, Van Denel S, Zaenen I, Schilpera R, Schell J (1974) Large Plasmid in Agrobacterium tumefaciens essential for crown gall-inducing ability. Nature 252:169–170PubMedCrossRefGoogle Scholar
  40. Xiang CB, Han P, Lutziger I, Wang K, Oliver DJ (1999) A mini binary vector series for plant transformation. Plant Mol Biol 40:711–717PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Institute of BiochemistryChristian Albrechts UniversityKielGermany
  2. 2.Leibniz Institute of Plant Genetics and Crop Plant Research (IPK)GaterslebenGermany

Personalised recommendations